MD Anderson Cancer Center, Department of Leukemia
Houston, Texas, United States
Cancer treatment center in Houston, Texas
1515 Holcombe Blvd, Houston, TX 77030
About MD Anderson Cancer Center, Department of Leukemia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
MingSight Pharmaceuticals, Inc
1
NS Pharma, Inc.
1
Clinical Trials at MD Anderson Cancer Center, Department of Leukemia
During the past decade, MD Anderson Cancer Center, Department of Leukemia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
2011-06-01
2020-04-22
Completed
77
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MD Anderson Cancer Center, Department of Leukemia
According to Clinical.Site data, the most researched conditions in "MD Anderson Cancer Center, Department of Leukemia" are
"Aggressive Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Post-Essential Thrombocythemia Myelofibrosis" (1 trials), "Post-Polycythemia Vera Myelofibrosis" (1 trials) and "Primary Myelofibrosis" (1 trials). Many other conditions were trialed in "MD Anderson Cancer Center, Department of Leukemia" in a lesser frequency.
Clinical Trials Intervention Types at MD Anderson Cancer Center, Department of Leukemia
Most popular intervention types in "MD Anderson Cancer Center, Department of Leukemia" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "MS-553" (1 trials), "NS-018" (1 trials), "Rituximab" (1 trials), "acalabrutinib" (1 trials) and "obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MD Anderson Cancer Center, Department of Leukemia
The vast majority of trials in "MD Anderson Cancer Center, Department of Leukemia" are
2 trials for "All" genders.
Clinical Trials Status at MD Anderson Cancer Center, Department of Leukemia
Currently, there are NaN active trials in "MD Anderson Cancer Center, Department of Leukemia".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MD Anderson Cancer Center, Department of Leukemia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MD Anderson Cancer Center, Department of Leukemia, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".